Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Forest Laboratories
• Treatments: Ceftaroline fosamil; Cephalosporins

Criteria

Inclusion Criteria:

• Hospitalized and receiving antibiotic therapy for treatment of a suspected infection of any type

• Body mass index (weight [kg]/height squared [m2]) of no more than 30

• Males and females between 12 and 17 years of age, inclusive

Exclusion Criteria:

• History of any hypersensitivity or allergic reaction to any β-lactam antimicrobial

• Past or current history of epilepsy or seizure disorder

• Critically ill or unstable patients